MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Net loss-$81,270K (0.02%↑ Y/Y)Loss before incometaxes-$81,249K (0.02%↑ Y/Y)Provision for income taxes$21K (16.67%↑ Y/Y)Interest income$7,155K (29.85%↑ Y/Y)Pharma TestingServices$48,661K Population Sequencing$11,766K (58.36%↑ Y/Y)Enterprise Sales$5,885K (-76.80%↓ Y/Y)Clinical Diagnostic$2,018K (165.88%↑ Y/Y)Other$1,318K (980.33%↑ Y/Y)Loss from operations-$88,057K (-28.99%↓ Y/Y)Revenue$69,648K (-17.69%↓ Y/Y)Interest expense$205K (754.17%↑ Y/Y)Other income(expense), net-$142K (99.23%↑ Y/Y)Total costs andexpenses$157,705K (3.16%↑ Y/Y)Cost of revenue$53,871K (-6.78%↓ Y/Y)Selling, general andadministrative$53,570K (15.99%↑ Y/Y)Research and development$50,264K (2.78%↑ Y/Y)
Income Statement
source: myfinsight.com

Personalis, Inc. (PSNL)

Personalis, Inc. (PSNL)